Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose in Dialysis Fluid for Hemodialysis
NCT00278057Phase 4Completed
- Sponsor
- Regionshospitalet Holstebro
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of glucose in end stage renal disease (ESRD) (2 arms), sponsored by Regionshospitalet Holstebro. Primary endpoints: Blood Pressure, Blood Glucose and 1 more. Started May 2003; status: completed.
02
Drugs
glucose
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00278057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278057.